Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Background and objective: It is unclear whether the severity of functional limitation resulting from IPF affects the response to pulmonary rehabilitation. The aim of this study was to compare the outcomes of rehabilitation in patients with IPF, who were grouped according to the Medical Research Coun...
| Main Authors: | Kozu, R., Jenkins, Susan, Senjyu, H. |
|---|---|
| Format: | Journal Article |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/34221 |
Similar Items
Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
by: Kuzu, R., et al.
Published: (2011)
by: Kuzu, R., et al.
Published: (2011)
Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council Dyspnea Grade
by: Kozu, R., et al.
Published: (2014)
by: Kozu, R., et al.
Published: (2014)
Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
by: Kozu, R., et al.
Published: (2010)
by: Kozu, R., et al.
Published: (2010)
International comparative epidemiology of idiopathic pulmonary fibrosis
by: Hutchinson, John
Published: (2017)
by: Hutchinson, John
Published: (2017)
The role of galectin-3 in the development of idiopathic pulmonary fibrosis
by: Parmar, Nimesh
Published: (2019)
by: Parmar, Nimesh
Published: (2019)
The role of Interleukin-33 in the development of idiopathic pulmonary fibrosis
by: Stephenson, Katherine
Published: (2021)
by: Stephenson, Katherine
Published: (2021)
Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
by: Pasini, Alice, et al.
Published: (2016)
by: Pasini, Alice, et al.
Published: (2016)
Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
by: Pasini, Alice, et al.
Published: (2016)
by: Pasini, Alice, et al.
Published: (2016)
The potential therapeutic effect of manipulating the extracellular matrix in idiopathic pulmonary fibrosis
by: Philp, Christopher J.
Published: (2016)
by: Philp, Christopher J.
Published: (2016)
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)
by: Hutchinson, John P., et al.
Published: (2015)
Physical activity and pulmonary rehabilitation
by: Alison, J., et al.
Published: (2013)
by: Alison, J., et al.
Published: (2013)
Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)
by: Liu, Yi-Chia
Published: (2014)
The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial
by: Lee, A., et al.
Published: (2010)
by: Lee, A., et al.
Published: (2010)
Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century
by: Hutchinson, John P., et al.
Published: (2014)
by: Hutchinson, John P., et al.
Published: (2014)
cAMP mediated regulation of fibroblast to myofibroblast differentiation in idiopathic pulmonary fibrosis
by: Wright, Rebecca
Published: (2016)
by: Wright, Rebecca
Published: (2016)
Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
by: Dalleywater, William, et al.
Published: (2014)
by: Dalleywater, William, et al.
Published: (2014)
Investigations into novel small molecules as potential treatments for idiopathic pulmonary fibrosis and malaria
by: Park, Jozef
Published: (2022)
by: Park, Jozef
Published: (2022)
Comorbidities and Medication Burden in Patients with Chronic Obstructive Pulmonary Disease Attending Pulmonary Rehabilitation
by: Noteboom, Ben, et al.
Published: (2014)
by: Noteboom, Ben, et al.
Published: (2014)
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
by: Maher, Toby M., et al.
Published: (2017)
by: Maher, Toby M., et al.
Published: (2017)
A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis
by: Coward, William R., et al.
Published: (2014)
by: Coward, William R., et al.
Published: (2014)
Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study
by: Navaratnam, Vidya, et al.
Published: (2014)
by: Navaratnam, Vidya, et al.
Published: (2014)
Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Barratt, Shaney L., et al.
Published: (2018)
by: Barratt, Shaney L., et al.
Published: (2018)
Interplay between EZH2 and G9a regulates CXCL10 gene repression in idiopathic pulmonary fibrosis
by: Coward, William R., et al.
Published: (2017)
by: Coward, William R., et al.
Published: (2017)
Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study
by: Dallywater, William, et al.
Published: (2015)
by: Dallywater, William, et al.
Published: (2015)
Optimising function in COPD: Physical activity and pulmonary rehabilitation
by: Alison, J., et al.
Published: (2013)
by: Alison, J., et al.
Published: (2013)
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
by: Jenkins, R. Gisli, et al.
Published: (2015)
by: Jenkins, R. Gisli, et al.
Published: (2015)
Pulmonary rehabilitation after acute exacerbsation of chronic obstructive pulmonary disease in patients who previously completed a pulmonary rehabilitation program
by: Carr, S., et al.
Published: (2009)
by: Carr, S., et al.
Published: (2009)
Community-based pulmonary rehabilitation in a non-healthcare facility is feasible and effective
by: Cecins, N., et al.
Published: (2017)
by: Cecins, N., et al.
Published: (2017)
Multimorbidity in patients with COPD and pulmonary rehabilitation
by: Hakamy, Ali
Published: (2018)
by: Hakamy, Ali
Published: (2018)
Physical Activity of Patients with Chronic Obstructive Pulmonary Disease: Implications for Pulmonary Rehabilitation
by: Hirayama, Fumi, et al.
Published: (2008)
by: Hirayama, Fumi, et al.
Published: (2008)
Six-minute walk test in pulmonary rehabilitation : Do all patients need a practice test?
by: Jenkins, Susan, et al.
Published: (2010)
by: Jenkins, Susan, et al.
Published: (2010)
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
by: Allen, Richard J., et al.
Published: (2017)
by: Allen, Richard J., et al.
Published: (2017)
Refining in-vivo models of pulmonary fibrosis
by: Habgood, Anthony
Published: (2018)
by: Habgood, Anthony
Published: (2018)
State of the art : How to set up a pulmonary rehabilitation program
by: Jenkins, Susan, et al.
Published: (2010)
by: Jenkins, Susan, et al.
Published: (2010)
Reduction in hospitalisation following pulmonary rehablitaton in patients with COPD
by: Cecins, Nola, et al.
Published: (2008)
by: Cecins, Nola, et al.
Published: (2008)
Australian and New Zealand Pulmonary Rehabilitation Guidelines
by: Alison, J., et al.
Published: (2017)
by: Alison, J., et al.
Published: (2017)
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis
by: Hobbs, Brian D., et al.
Published: (2017)
by: Hobbs, Brian D., et al.
Published: (2017)
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
by: Hurley, M., et al.
Published: (2015)
by: Hurley, M., et al.
Published: (2015)
The use of the practice walk test in pulmonary rehabilitation program: National COPD Audit Pulmonary Rehabilitation Workstream
by: Hakamy, Ali, et al.
Published: (2017)
by: Hakamy, Ali, et al.
Published: (2017)
Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines. An official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation.
by: Garvey, C., et al.
Published: (2016)
by: Garvey, C., et al.
Published: (2016)
Similar Items
-
Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
by: Kuzu, R., et al.
Published: (2011) -
Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council Dyspnea Grade
by: Kozu, R., et al.
Published: (2014) -
Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
by: Kozu, R., et al.
Published: (2010) -
International comparative epidemiology of idiopathic pulmonary fibrosis
by: Hutchinson, John
Published: (2017) -
The role of galectin-3 in the development of idiopathic pulmonary fibrosis
by: Parmar, Nimesh
Published: (2019)